The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
This year’s honorees inspire us with their unwavering dedication to helping colleagues grow and achieve – even from a distance.
KPWHRI responded to the COVID-19 hurricane with actions to improve health worldwide.
In a Viewpoint for JAMA, KPWHRI’s Dr. Mike Jackson plans ahead to meet the challenges of continuing to evaluate new vaccines.
Experts in health data discuss a widely used data model — its origin, organization, and current applications
KPWHRI psychologist and researcher Ben Balderson, PhD, shares advice for keeping our spirits up during this most unusual holiday season.
Dr. Jennifer McClure explains why now may be the perfect time to stop smoking.
